Avoid common mistakes on your manuscript.
Correction to: Clinical and Translational Oncology https://doi.org/10.1007/s12094-022-03046-9
In this article the caption to Fig. 2 was incorrect and should have been as follows.
Fig. 2 Updated protocol for multiple biomarker testing on samples from patients with NSCLC. The number of sections for each test is shown in blue. aThe requirements for nucleic acid extraction for individual molecular testing or for extended genetic panels (NGS) are variable. Figure modified from Conde et al. (confidential, submitted). AC adenocarcinoma, ALK anaplastic lymphoma kinase, EGFR epidermal growth factor receptor, FISH fluorescence in situ hybridisation, H&E haematoxylin and eosin, IHC immunohistochemistry, KRAS kirsten rat sarcoma virus, MET mesenchymal epithelial transition factor, NGS next-generation sequencing, NTRK neurotrophic tyrosine receptor kinase, NSCLCNOS non-small-cell lung carcinoma—not otherwise specified, PCR polymerase chain reaction, RET rearranged during transfection, ROS1 c-ros oncogene 1, PD-L1 programmed death ligand-1
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Isla, D., Lozano, M.D., Paz-Ares, L. et al. Correction to: New update to the guidelines on testing predictive biomarkers in non‑small‑cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. Clin Transl Oncol 25, 1488 (2023). https://doi.org/10.1007/s12094-023-03103-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-023-03103-x